 | This article contains content that is written like an advertisement .(June 2011) |
| Type | Nonprofit organization |
|---|---|
| Founded | Toronto, Ontario, Canada |
| Headquarters | MaRS Discovery District |
Ontario Genomics, formerly the Ontario Genomics Institute, is a not-for-profit organization that manages genomics research projects and platforms. Ontario Genomics is funded by the Ontario government and the federal research agency Genome Canada.
Ontario Genomics was established in 2000, following a landmark decision by the Canadian Government to support the science of genomics.[ citation needed ]
Since its inception, Ontario Genomics has:
Celera is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of Applera, spun off into an independent company in 2008, and finally acquired by Quest Diagnostics in 2011.
Marco A. Marra is a Distinguished Scientist and Director of Canada's Michael Smith Genome Sciences Centre at the BC Cancer Research Centre and Professor of Medical Genetics at the University of British Columbia (UBC). He also serves as UBC Canada Research Chair in Genome Science for the Canadian Institutes of Health Research and is an inductee in the Canadian Medical Hall of Fame. Marra has been instrumental in bringing genome science to Canada by demonstrating the pivotal role that genomics can play in human health and disease research.
Gary T. Goodyear is a Canadian politician. He was a member of the House of Commons of Canada from 2004 to 2015, having been elected to represent the riding of Cambridge as a Conservative in 2004. On October 30, 2008 he was named Minister of State for Science & Technology within Prime Minister Stephen Harper's Cabinet. Goodyear was re-elected in the May 2nd elections in 2011 and returned to Stephen Harper's cabinet as Minister of State for Science & Technology. He was replaced in this capacity by Greg Rickford on July 15, 2013.
Joseph Louis Rotman,, was a noted Canadian businessman and philanthropist. Rotman was the founder, benefactor and member of many successful organizations, such as the Clairvest Group Inc., the Rotman Research Institute, the Rotman School of Management, and the Rotman Institute of Philosophy. Throughout his life, he received three honorary degrees, as well as an induction into the Canadian Business Hall of Fame. He is well-regarded for donating his time and financial assistance to numerous philanthropic causes including the arts, education and healthcare.
The Ministry of Research, Innovation and Science was a government ministry of the Province of Ontario. Founded in 2005, the ministry became part of the Ministry of Economic Development and Innovation in 2011. It intermittently became a separate ministry in again from 2013 until 2018, when it became part of the Ministry of Economic Development, Job Creation and Trade.
Medical research, also known as experimental medicine, encompasses a wide array of research, extending from "basic research", – involving fundamental scientific principles that may apply to a preclinical understanding – to clinical research, which involves studies of people who may be subjects in clinical trials. Within this spectrum is applied research, or translational research, conducted to expand knowledge in the field of medicine.
The Lunenfeld-Tanenbaum Research Institute is a medical research institute in Toronto, Ontario and part of the Sinai Health System. It was originally established in 1985 as the Samuel Lunenfeld Research Institute, the research arm of Mount Sinai Hospital, by an endowment from the Lunenfeld and Kunin families. It was renamed to the current name on June 24, 2013, after a $35 million donation from Larry and Judy Tanenbaum.
Piers David Nash is an entrepreneur, cancer biology professor, data evangelist, writer and technology futurist. He is the son of academic Roger Nash.
The Ontario Disability Support Program (ODSP) is a means-tested government-funded last resort income support paid for qualifying residents in the province of Ontario, Canada, who are at least eighteen years of age and have a disability. ODSP and Ontario Works (OW) are the two main components of Ontario's social assistance system. Like most social programs in Canada, the program is funded by the government of the province. The Ministry of Community and Social Services is responsible for ODSP and OW.
Renaissance Computing Institute (RENCI) was launched in 2004 as a collaboration involving the State of North Carolina, University of North Carolina at Chapel Hill (UNC-CH), Duke University, and North Carolina State University. RENCI is organizationally structured as a research institute within UNC-CH, and its main campus is located in Chapel Hill, NC, a few miles from the UNC-CH campus. RENCI has engagement centers at UNC-CH, Duke University (Durham), and North Carolina State University (Raleigh).
The Genome-based Research and Population Health International Network (GRaPH-Int) is an international collaboration of experts and researchers focused in the area of population health. The principal goal of the network is to promote the translation of genome-based science and technology into improvements in population health.
Expenditures by Canadian universities on scientific research and development accounted for about 40% of all spending on scientific research and development in Canada in 2006.
The International Cancer Genome Consortium (ICGC) is a voluntary scientific organization that provides a forum for collaboration among the world's leading cancer and genomic researchers. The ICGC was launched in 2008 to coordinate large-scale cancer genome studies in tumours from 50 cancer types and/or subtypes that are of main importance across the globe.
The Centre for Applied Genomics is a genome centre in the Research Institute of The Hospital for Sick Children, and is affiliated with the University of Toronto. TCAG also operates as a Science and Technology Innovation Centre of Genome Canada, with an emphasis on next-generation sequencing (NGS) and bioinformatics support. Research at TCAG focuses on the genetic and genomic basis of human variability, health and disease, including research on the genetics of autism spectrum disorder and structural variation of the human genome. The centre is located in the Peter Gilgan Centre for Research and Learning in downtown Toronto, Canada.
Lawrence B. Schook is the vice president for research at the University of Illinois. He oversees the $1 billion research portfolio across all three campuses. A scholar in comparative genomics and the exploitation of genomic diversity to understand traits and disease, Dr. Schook focuses his research on genetic resistance to disease, regenerative medicine, and using genomics to create animal models for biomedical research. He led the international pig genome-sequencing project, which produced a draft of the pig genome allowing researchers to offer insights into diseases that afflict pigs and humans.
The acronyms ELSI and ELSA refer to research activities that anticipate and address ethical, legal and social implications (ELSI) or aspects (ELSA) of emerging sciences, notably genomics and nanotechnology. ELSI was conceived in 1988 when James Watson, at the press conference announcing his appointment as director of the Human Genome Project (HGP), suddenly and somewhat unexpectedly declared that the ethical and social implications of genomics warranted a special effort and should be directly funded by the National Institutes of Health.
NIH Office of Science Policy is the primary advisor to the Director of the NIH on matters of biomedical research policy issues that are of significance to the agency, the research community, and the public. The office also works with stakeholders within and outside of NIH to develop policies that promote progress in the life sciences. The current Acting NIH Associate Director for Science Policy and Acting Director of the NIH Office of Science Policy is Lyric Jorgenson, Ph.D.
ICES is an independent, non-profit corporation that applies the study of health informatics for health services research and population-wide health outcomes research in Ontario, Canada, using data collected through the routine administration of Ontario's system of publicly funded health care.
The Global Alliance for Genomics and Health (GA4GH) is an international consortium that is developing standards for responsibly collecting, storing, analyzing, and sharing genomic data in order to enable an "internet of genomics". GA4GH was founded in 2013.
PTX-COVID19-B is a messenger RNA (mRNA)-based COVID-19 vaccine, a vaccine for the prevention of the COVID-19 disease caused by an infection of the SARS-CoV-2 coronavirus, created by Providence Therapeutics—a private Canadian drug company co-founded by Calgary, Alberta-based businessman Brad T. Sorenson and San Francisco–based Eric Marcusson in 2013. A team of eighteen working out of Sunnybrook Research Institute in Toronto, Ontario developed PTX-COVID19-B in less than four weeks, according to the Calgary Herald. Human trials with sixty volunteers began on January 26, 2021, in Toronto.
